AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Potential of GLP1 Mimic Drugs for Weight Loss and Psychiatric Behavior
This chapter explores the potential of GLP1 mimic drugs like ozempic for weight loss and psychiatric behavior. It discusses the promising results of phase two trials, concerns about side effects and muscle loss, and the possibility of pairing these drugs with muscle retention or growth drugs. The conversation also addresses the lack of effective solutions for obesity and the potential benefits of weight loss drugs.